Cargando…

Quantitative analysis of metabolic parameters at (18)F-fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors

To evaluate the utility of (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) for predicting the malignancy of anterior mediastinal tumors, the present study retrospectively examined a total of 105 consecutive patients who underwent surgical resection of anterior mediastinal tumors at...

Descripción completa

Detalles Bibliográficos
Autores principales: Yajima, Toshiki, Mogi, Akira, Shimizu, Kimihiro, Kosaka, Takayuki, Ohtaki, Yoichi, Obayashi, Kai, Nakazawa, Seshiru, Nakajima, Takahito, Tsushima, Yoshito, Shirabe, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038926/
https://www.ncbi.nlm.nih.gov/pubmed/32194681
http://dx.doi.org/10.3892/ol.2020.11276
_version_ 1783500730112409600
author Yajima, Toshiki
Mogi, Akira
Shimizu, Kimihiro
Kosaka, Takayuki
Ohtaki, Yoichi
Obayashi, Kai
Nakazawa, Seshiru
Nakajima, Takahito
Tsushima, Yoshito
Shirabe, Ken
author_facet Yajima, Toshiki
Mogi, Akira
Shimizu, Kimihiro
Kosaka, Takayuki
Ohtaki, Yoichi
Obayashi, Kai
Nakazawa, Seshiru
Nakajima, Takahito
Tsushima, Yoshito
Shirabe, Ken
author_sort Yajima, Toshiki
collection PubMed
description To evaluate the utility of (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) for predicting the malignancy of anterior mediastinal tumors, the present study retrospectively examined a total of 105 consecutive patients who underwent surgical resection of anterior mediastinal tumors at Gunma University Hospital after undergoing a preoperative FDG-PET scan. Patients were divided into benign and malignant groups in accordance with the following three classification systems: i) Clinical classification, benign or malignant (thymoma and carcinoma); ii) recurrence-based classification, low-risk recurrence (benign and low-risk thymoma) or high-risk recurrence (high-risk thymoma and carcinoma); and iii) pathological classification, benign (benign and thymoma) or malignant (carcinoma). The present study analyzed the differences between the benign and malignant groups in terms of FDG-PET parameters, including maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV) and total lesion glycolysis (TLG). The malignant group exhibited a significantly greater SUVmax than the benign group according to all classification systems. By contrast, there was only a slight difference between groups in volume-based metabolic parameters (MTV and TLG) using the clinical classification, and no intergroup differences using the recurrence-based and pathological classifications. The area under the curve in receiver-operating characteristic curve analysis for predicting malignancy was significantly greater for SUVmax than for volume-based metabolic parameters using all classification methods. The respective optimal cut-off value, sensitivity and specificity of SUVmax to predict malignancy were 1.77, 92.0 and 87.0% for the clinical classification, 2.54, 93.6 and 60.3% for the recurrence-based classification, and 5.15, 78.9 and 90.7% for the pathological classification. SUVmax was the most useful parameter for predicting the malignancy of anterior mediastinal tumors.
format Online
Article
Text
id pubmed-7038926
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-70389262020-03-19 Quantitative analysis of metabolic parameters at (18)F-fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors Yajima, Toshiki Mogi, Akira Shimizu, Kimihiro Kosaka, Takayuki Ohtaki, Yoichi Obayashi, Kai Nakazawa, Seshiru Nakajima, Takahito Tsushima, Yoshito Shirabe, Ken Oncol Lett Articles To evaluate the utility of (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) for predicting the malignancy of anterior mediastinal tumors, the present study retrospectively examined a total of 105 consecutive patients who underwent surgical resection of anterior mediastinal tumors at Gunma University Hospital after undergoing a preoperative FDG-PET scan. Patients were divided into benign and malignant groups in accordance with the following three classification systems: i) Clinical classification, benign or malignant (thymoma and carcinoma); ii) recurrence-based classification, low-risk recurrence (benign and low-risk thymoma) or high-risk recurrence (high-risk thymoma and carcinoma); and iii) pathological classification, benign (benign and thymoma) or malignant (carcinoma). The present study analyzed the differences between the benign and malignant groups in terms of FDG-PET parameters, including maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV) and total lesion glycolysis (TLG). The malignant group exhibited a significantly greater SUVmax than the benign group according to all classification systems. By contrast, there was only a slight difference between groups in volume-based metabolic parameters (MTV and TLG) using the clinical classification, and no intergroup differences using the recurrence-based and pathological classifications. The area under the curve in receiver-operating characteristic curve analysis for predicting malignancy was significantly greater for SUVmax than for volume-based metabolic parameters using all classification methods. The respective optimal cut-off value, sensitivity and specificity of SUVmax to predict malignancy were 1.77, 92.0 and 87.0% for the clinical classification, 2.54, 93.6 and 60.3% for the recurrence-based classification, and 5.15, 78.9 and 90.7% for the pathological classification. SUVmax was the most useful parameter for predicting the malignancy of anterior mediastinal tumors. D.A. Spandidos 2020-03 2020-01-09 /pmc/articles/PMC7038926/ /pubmed/32194681 http://dx.doi.org/10.3892/ol.2020.11276 Text en Copyright: © Yajima et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Yajima, Toshiki
Mogi, Akira
Shimizu, Kimihiro
Kosaka, Takayuki
Ohtaki, Yoichi
Obayashi, Kai
Nakazawa, Seshiru
Nakajima, Takahito
Tsushima, Yoshito
Shirabe, Ken
Quantitative analysis of metabolic parameters at (18)F-fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors
title Quantitative analysis of metabolic parameters at (18)F-fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors
title_full Quantitative analysis of metabolic parameters at (18)F-fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors
title_fullStr Quantitative analysis of metabolic parameters at (18)F-fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors
title_full_unstemmed Quantitative analysis of metabolic parameters at (18)F-fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors
title_short Quantitative analysis of metabolic parameters at (18)F-fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors
title_sort quantitative analysis of metabolic parameters at (18)f-fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038926/
https://www.ncbi.nlm.nih.gov/pubmed/32194681
http://dx.doi.org/10.3892/ol.2020.11276
work_keys_str_mv AT yajimatoshiki quantitativeanalysisofmetabolicparametersat18ffluorodeoxyglucosepositronemissiontomographyinpredictingmalignantpotentialofanteriormediastinaltumors
AT mogiakira quantitativeanalysisofmetabolicparametersat18ffluorodeoxyglucosepositronemissiontomographyinpredictingmalignantpotentialofanteriormediastinaltumors
AT shimizukimihiro quantitativeanalysisofmetabolicparametersat18ffluorodeoxyglucosepositronemissiontomographyinpredictingmalignantpotentialofanteriormediastinaltumors
AT kosakatakayuki quantitativeanalysisofmetabolicparametersat18ffluorodeoxyglucosepositronemissiontomographyinpredictingmalignantpotentialofanteriormediastinaltumors
AT ohtakiyoichi quantitativeanalysisofmetabolicparametersat18ffluorodeoxyglucosepositronemissiontomographyinpredictingmalignantpotentialofanteriormediastinaltumors
AT obayashikai quantitativeanalysisofmetabolicparametersat18ffluorodeoxyglucosepositronemissiontomographyinpredictingmalignantpotentialofanteriormediastinaltumors
AT nakazawaseshiru quantitativeanalysisofmetabolicparametersat18ffluorodeoxyglucosepositronemissiontomographyinpredictingmalignantpotentialofanteriormediastinaltumors
AT nakajimatakahito quantitativeanalysisofmetabolicparametersat18ffluorodeoxyglucosepositronemissiontomographyinpredictingmalignantpotentialofanteriormediastinaltumors
AT tsushimayoshito quantitativeanalysisofmetabolicparametersat18ffluorodeoxyglucosepositronemissiontomographyinpredictingmalignantpotentialofanteriormediastinaltumors
AT shirabeken quantitativeanalysisofmetabolicparametersat18ffluorodeoxyglucosepositronemissiontomographyinpredictingmalignantpotentialofanteriormediastinaltumors